Boehringer Ingelheim launches new portal to facilitate access to research assets
lkfitz's bookmarks 2017-11-22
Summary:
"Boehringer Ingelheim has announced the launch of opnMe.com, a new platform offering free and open access to many of its medical assets for research purposes.
Through this online portal, scientists around the world will be able to gain access to selected preclinical molecules for non-clinical investigation, including compounds focused on some of the most relevant targets in biomedical research."